Description
Topotecan is an anticancer chemotherapeutic compound that inhibits topoisomerase I and is clinically used to treat various cancers. Topotecan induces apoptosis in retinocytoma cells and ovarian cancer cells.
Product Unit Size | Cost | Quantity | Stock |
---|
Topotecan is an anticancer chemotherapeutic compound that inhibits topoisomerase I and is clinically used to treat various cancers. Topotecan induces apoptosis in retinocytoma cells and ovarian cancer cells.
Cas No. | 119413-54-6 |
---|---|
Purity | ≥97% |
Formula | C23H25N3O5 • HCl |
Formula Wt. | 457.91 |
Chemical Name | (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9- dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]- quinoline-3,14(4H,12H)-dione hydrochloride |
IUPAC Name | (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;hydrochloride |
Synonym | Hycamtin, NSC-609669, SKF-104864A |
Melting Point | 213-218°C(dec.) |
Solubility | Soluble in methanol, water (92 mg/mL at 25 °C), DMSO (92 mg/mL at 25 °C), ethanol (<1 mg/mL at 25 °C), and 1: 1 solution of DMSO: PBS (pH 7.2, ~0.5 mg/mL). |
Appearance | Pale Yellow Crystal Powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Attia SM, Ahmad SF, Abd-Ellah MF, et al. Germ cell mutagenicity of topoisomerase I inhibitor topotecan detected in the male mouse-dominant lethal study. Food Chem Toxicol. 2013 Dec;62:470-4. PMID: 24036143.
Zhang M, Shan BE, Yuan NF, et al. Effect of topotecan on retinocytoma cell apoptosis and expression of Livin and PTEN. Chin Med J (Engl). 2013 Jan;126(2):340-4. PMID: 23324287.
Caltová K, Cervinka M. Antiproliferative effects of selected chemotherapeutics in human ovarian cancer cell line A2780. Acta Medica (Hradec Kralove). 2012;55(3):116-24. PMID: 23297519.
Sonabend AM, Stuart RM, Yun J, et al. Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump. Neuro Oncol. 2011 Aug;13(8):886-893. PMID: 21750007.
ERK1/2 inhibitor.
PI3K and mTOR inhibitor.
Aldose reductase inhibitor.
Potential PKD binding agent.
Endogenous APP peptide cleavage product, primar...
PP2A activator, Sphk1 and PKC inhibitor.
Rifamycin derivative, induces pore formation in...
Cyclic peptide; calcineurin inhibitor.
Anxiolytic-like agent that stimulates angiogene...
Endogenous hormone and neurotransmitter involve...
A peroxisome proliferator-activated receptor ag...
Endogenous peptide neurotransmitter, involved i...
Oxidized non-cylic hexose sugar.
Polypeptide antibiotic produced from Streptomyc...
Estradiol metabolite; microtubule depolymerizat...
AChE inhibitor.
Polyether Ca2+ ionophore.
Nucleoside (adenosine) analog; DNA chain termin...
R,R enantiomer of formoterol; β2-adrenergic an...
5-Fluorouracil prodrug, pyrimidine nucleoside a...